Report Categories
View AllRecent Articles
View All
DBRGJ DigiBridge J identifies targeted digital infrastructure investments as core strategic priority for the quarter
NRXP NRX Pharmaceuticals rises 352 percent even after posting a far wider than expected Q4 2025 loss
Atea Pharma AVIR Stock Investment Risks Buying Pressure 20260420
OS OneStream delivers strong Q4 2025 results with 137 percent EPS beat and 23 percent year over year revenue growth
Phillips 66 PSX Advances Western Gateway Pipeline Amid Valuation Headwinds and Regulatory Risks
What Toyota TM is doing that smarter investors notice Tick Up 20260506
iShares Silver Trust SLV Strategic Allocation to Silver Miners Amid Record Institutional Inflows
The fundamentals driving Steven Madden SHOO everyone should understand Volatility Increases 20260508
Schwab US REIT ETF SCHH Positioned for Sector Tailwinds As US Mortgage Rates Fall Below 6 Threshold
Constellation Brands STZ Up 255 Is There More Room to Run 20260518
Travelzoo TZOO Unchanged at 929 RangeBound Trading 20260518
SP 500 Stretches Weekly Win Streak to Seven Despite Lukewarm TrumpXi Summit
Everpure PSTG Stock Jumps 448 Approaching 7119 20260518
MercadoLibre Stock Volatility Raises Questions Key Factors for Investor Consideration
Securitize Reports Record Revenue Growth of 39 Ahead of Cantor SPAC Merger
Chubb CB Q1 2026 Earnings Beat Revenue NA EPS 682
Chinese EV Makers Resuscitate Dormant Western Auto Factories
Amprius Technologies Inc AMPX Q1 2026 Earnings Loss Wider Than Expected Shares Buck the Trend
CLSK Q1 2026 Earnings EPS Misses Estimates by Wide Margin Shares Edge Higher
PMTW Q1 2026 Earnings Significant EPS Miss as Trust Reports 016 vs 038 Estimate
agilon health Q1 2026 Earnings Massive EPS Beat Drives Stock Surge
Veru Inc Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline
AFGE Posts Modest Gains as YieldSeeking Capital Flows Support Subordinated Debt
Tutor Perini TPC Posts Modest Gains as Support Holds Above 7156
BristolMyers Squibb BMY Declines 218 Support Levels in Focus as Stock Holds Above 55
Toll Brothers TOL Holds Sluggish as Sellers Test Key Support Zone
PDS Biotechnology Q1 2026 Earnings EPS Beat on Narrower Loss Clinical Progress in Focus
Enveric Biosciences Inc ENVB Q4 2024 Earnings Massive EPS Miss Highlights Ongoing Cash Burn and No Revenue
ERAS Q1 2026 Earnings WiderthanExpected Loss Sends Shares Lower
ROKU Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction
RGEN Q1 2026 Earnings EPS Surges Past Estimates by 22 Revenue Details Not Disclosed
KW Q1 2026 Earnings Strong EPS Surprise Amidst Challenging Market